Allogenica

Biotechnology company specializing in the development of allogeneic CAR-T therapies for cancer treatment

placeLyon, Auvergne Rhone Alpes, France calendar_todayFounded 2022 language allogenica.com

Social engagement

Social engagement: 2.3K social following, 7 posts in the last 12 months — below the industry typical range.

Investor mix

1 investor on record.

Investor typeCountShare
Other / undisclosed1100%

Recent activity

26 May 2026
Event
ICGT2026
6 May 2026
Event
Asia Summit on Global Health 2026
26 Mar 2026
Milestone
Coming soon